SaposnikGGalanosLCGuerreroR, et alThe World Stroke Academy: a World Stroke Organization global pathway to improve knowledge in stroke care. Int J Stroke2022; 17: 829–834.
2.
MarkusHSMichelP.Treatment of posterior circulation stroke: acute management and secondary prevention. Int J Stroke2022; 17: 723–732.
3.
ParodiLMyserlisEPChungJ, et alShared genetic background between SARS-CoV-2 infection and large artery stroke. Int J Stroke2022; 17: 873–880.
4.
MarkusHSBraininM.COVID—19 and stroke—a global World Stroke Organization perspective. Int J Stroke2020; 15: 361–364.
5.
SweidAHammoudBBekelisK, et alCerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke2020; 15: 733–742.
6.
NannoniSde GrootRBellSMarkusHS.Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke2021; 16: 137–149.
7.
KihiraSScheffleinJMahmoudiK, et alAssociation of coronavirus disease (COVID-19) with large vessel occlusion strokes: a case-control study. Am J Roentgenol2021; 216: 150–156.
8.
SouthKMcCullochLMcCollBWElkindMSAllanSMSmithCJ.Preceding infection and risk of stroke: an old concept revived by the COVID-19 pandemic. Int J Stroke2020; 15: 722–732.
MarkusHS.The return of in-person stroke conferences, thrombectomy for basilar occlusion, and advances in intracerebral hemorrhage. Int J Stroke2022; 17: 485–486.
11.
MartinsSOMont’AlverneFRebelloLC, et alThrombectomy for stroke in the public health care system of Brazil. N Engl J Med2020; 382: 2316–2326.
12.
de Castro-AfonsoLHNakiriGSFornazariVR, et alPerformance evolution over 645 acute stroke thrombectomies in a public Brazilian Healthcare Institution. Int J Stroke2021; 16: 927–934.
13.
de SouzaACMartinsSOPolanczykCA, et alCost-effectiveness of mechanical thrombectomy for acute ischemic stroke in Brazil: results from the RESILIENT trial. Int J Stroke2022; 17: 855–862.
14.
LuijtenSPCompagneKCvan EsAC, et alBrain atrophy and endovascular treatment effect in acute ischemic stroke: a secondary analysis of the MR CLEAN trial. Int J Stroke2022; 17: 881–888.
15.
BiesbroekJMBiesselsGJ.Diagnosing vascular cognitive impairment: current challenges and future perspectives. Int J Stroke. Epub ahead of print 30 January 2022. DOI: 10.1177/17474930211073387.
16.
GongJHarrisKTzourioC, et alSex differences in predictors for cognitive decline and dementia in people with stroke or transient ischemic attack in the PROGRESS trial. Int J Stroke2022; 17: 863–872.
17.
MacMahonSNealBTzourioC and PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet2001; 358: 1033–1041.
18.
SPRINT MIND Investigators for the SPRINT Research Group, WilliamsonJDPajewskiNM, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA2019; 321: 553–561.
19.
KotalczykAGuoYWangYLipGY and ChiOTEAF Registry Investigators. Are low doses of non-vitamin K antagonists effective in Chinese patients with atrial fibrillation? A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. Int J Stroke2022; 17: 848–854.